ArticleBMC infectious diseases2026
Integrative metabolite-protein interaction networks reveal potential pathways and biomarkers in sepsis.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a significant factor in morbidity and mortality, and the list of biomarkers that could be used to help identify and manage it is limited. We have herein, combined a set of 50 metabolites related to sepsis with a set of 171 proteins to build a protein-protein interaction network and then clustered the proteins included in the interaction network, performed pathway enrichment analysis, and provided a significance score (SScore) to rank the genes. The SScore is determined as the minus logarithm based 10 of the smallest false discovery rate-adjusted p-value in all the clusters, where a protein is located; the larger the result is the more the evidence of the relevance of the protein to sepsis. The use of this framework resulted in the prioritization of 125 higher-ranking Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways that included known mechanisms, which is complement and coagulation cascades and platelet activation, and novel mechanisms, including sphingolipid metabolism and glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The SScore highlighted existing sepsis-relevant genes, including, but not limited to, APOA1 and A2M, and the appearance of new candidates, including, but not limited to, IL18RAP and THBS1, capable of being used as previously unknown biomarkers. Such results provide a ranked list of pathways and genes that may guide future research on biomarker development and treatment of sepsis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.